{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:19Z","timestamp":1786980259693,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00467-025-06884-1","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T03:51:10Z","timestamp":1752637870000},"page":"3513-3519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4960-3083","authenticated-orcid":false,"given":"Isabella","family":"Guzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Becilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cappoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Labbadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Bufalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola M.","family":"Tomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"6884_CR1","doi-asserted-by":"publisher","unstructured":"Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O et al (2022) Waiting time for second kidney transplantation and mortality. Clin J Am Soc Nephrol 17:90\u201397. https:\/\/doi.org\/10.2215\/CJN.07620621","DOI":"10.2215\/CJN.07620621"},{"key":"6884_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/MOT.0000000000001131","volume":"29","author":"A Vo","year":"2024","unstructured":"Vo A, Ammerman N, Jordan SC (2024) Advances in desensitization for human leukocyte antigen incompatible kidney transplantation. Curr Opin Organ Transplant 29:104\u2013120. https:\/\/doi.org\/10.1097\/MOT.0000000000001131","journal-title":"Curr Opin Organ Transplant"},{"key":"6884_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000004279","volume":"107","author":"J Noble","year":"2023","unstructured":"Noble J, Jouve T, Malvezzi P, Rostaing L (2023) Desensitization in crossmatch-positive kidney transplant candidates. Transplantation 107:351\u2013360. https:\/\/doi.org\/10.1097\/TP.0000000000004279","journal-title":"Transplantation"},{"key":"6884_CR4","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1016\/S2352-3026(22)00225-3","volume":"9","author":"S Ghorashian","year":"2022","unstructured":"Ghorashian S, Jacoby E, De Moerloose B, Rives S, Bonney D, Shenton G, Bader P, Bodmer N, Quintana AM, Herrero B, Algeri M, Locatelli F, Vettenranta K, Gonzalez B, Attarbaschi A, Harris S, Bourquin JP, Baruchel A (2022) Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study. Lancet Haematol 9:e766\u2013e775. https:\/\/doi.org\/10.1016\/S2352-3026(22)00225-3","journal-title":"Lancet Haematol"},{"key":"6884_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA (2018) Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med 378:439\u2013448","journal-title":"N Engl J Med"},{"key":"6884_CR6","doi-asserted-by":"publisher","unstructured":"Mackensen A, M\u00fcller F, Mougiakakos D, B\u00f6ltz S, Wilhelm A, Aigner M, V\u00f6lkl S, Simon D, Kleyer A, Munoz L, Kretschmann S, Kharboutli S, Gary R, Reimann H, R\u00f6sler W, Uderhardt S, Bang H, Herrmann M, Ekici AB, Buettner C, Habenicht KM, Winkler TH, Kr\u00f6nke G, Schett G (2022) Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus Nat Med. 28:2124\u20132132. https:\/\/doi.org\/10.1038\/s41591-022-02017-5. Erratum in: 10.1038\/s41591-022-02091-9","DOI":"10.1038\/s41591-022-02017-5"},{"key":"6884_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMc2107725","volume":"385","author":"D Mougiakakos","year":"2021","unstructured":"Mougiakakos D, Kr\u00f6nke G, V\u00f6lkl S, Kretschmann S, Aigner M, Kharboutli S, B\u00f6ltz S, Manger B, Mackensen A, Schett G (2021) CD19-targeted CAR T cells in refractory systemic lupus erythematosus. N Engl J Med 385:567\u2013569. https:\/\/doi.org\/10.1056\/NEJMc2107725","journal-title":"N Engl J Med"},{"key":"6884_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F M\u00fcller","year":"2024","unstructured":"M\u00fcller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, V\u00f6lkl S, Aigner M, Rothe T, Minopoulou I, Tur C, Knitza J, Kharboutli S, Kretschmann S, Vasova I, Spoerl S, Reimann H, Munoz L, Gerlach RG, Sch\u00e4fer S, Grieshaber-Bouyer R, Korganow AS, Farge-Bancel D, Mougiakakos D, Bozec A, Winkler T, Kr\u00f6nke G, Mackensen A, Schett G (2024) CD19 CAR T-cell therapy in autoimmune disease-a case series with follow-up. N Engl J Med 390:687\u2013700. https:\/\/doi.org\/10.1056\/NEJMoa2308917","journal-title":"N Engl J Med"},{"key":"6884_CR9","doi-asserted-by":"publisher","first-page":"101336","DOI":"10.1016\/j.xcrm.2023.101336","volume":"4","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Markmann C, Yu M, Agarwal D, Rostami S, Wang W, Liu C, Zhao H, Ochoa T, Parvathaneni K, Xu X, Li E, Gonzalez V, Khadka R, Hoffmann J, Knox JJ, Scholler J, Marcellus B, Allman D, Fraietta JA, Samelson-Jones B, Milone MC, Monos D, Garfall AL, Naji A, Bhoj VG (2023) Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies. Cell Rep Med 4:101336. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101336","journal-title":"Cell Rep Med"},{"key":"6884_CR10","doi-asserted-by":"publisher","first-page":"e001514","DOI":"10.1136\/jitc-2020-001514","volume":"9","author":"C Quintarelli","year":"2021","unstructured":"Quintarelli C, Guercio M, Manni S, Boffa I, Sinibaldi M, De Cecca S, Caruso S, Abbaszadeh Z, Camera A, Cembrola B, Ciccone R, Orfao A, Martin-Martin L, Gutierrez-Herrero S, Herrero-Garcia M, Cazzaniga G, Nunes V, Songia S, Marcatili P, Marin FI, Ruella M, Bertaina V, Vinti L, Del Bufalo F, Algeri M, Merli P, De Angelis B, Locatelli F (2021) Strategy to prevent epitope masking in CAR CD19+ B-cell leukemia blasts. J Immunother Cancer 9:e001514","journal-title":"J Immunother Cancer"},{"key":"6884_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1182\/blood.2023020023","volume":"142","author":"F Del Bufalo","year":"2023","unstructured":"Del Bufalo F, Becilli M, Rosignoli C, De Angelis B, Algeri M, Hanssens L, Gunetti M, Iacovelli S, Li Pira G, Girolami E, Leone G, Lazzaro S, Bertaina V, Sinibaldi M, Di Cecca S, Iaffaldano L, K\u00fcnkele A, Boccieri E, Del Baldo G, Pagliara D, Merli P, Carta R, Quintarelli C, Locatelli F (2023) Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed\/refractory BCP-ALL. Blood 142:146\u2013157. https:\/\/doi.org\/10.1182\/blood.2023020023","journal-title":"Blood"},{"key":"6884_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, Ciceri F, Corbacioglu S, Ellard R, Sanchez-Guijo F, J\u00e4ger U, Hildebrandt M, Hudecek M, Kersten MJ, K\u00f6hl U, Kuball J, Mielke S, Mohty M, Murray J, Nagler A, Rees J, Rioufol C, Saccardi R, Snowden JA, Styczynski J, Subklewe M, Thieblemont C, Topp M, Ispizua \u00c1U, Chen D, Vrhovac R, Gribben JG, Kr\u00f6ger N, Einsele H, Yakoub-Agha I (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol 33:259\u2013275. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.003","journal-title":"Ann Oncol"},{"key":"6884_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1182\/blood.2023020578","volume":"142","author":"K Rejeski","year":"2023","unstructured":"Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi A, Barba P, Bruno B, Benjamin R, Carrabba MG, Chabannon C, Ciceri F, Corradini P, Delgado J, Di Blasi R, Greco R, Houot R, Iacoboni G, J\u00e4ger U, Kersten MJ, Mielke S, Nagler A, Onida F, Peric Z, Roddie C, Ruggeri A, S\u00e1nchez-Guijo F, S\u00e1nchez-Ortega I, Schneidawind D, Schubert ML, Snowden JA, Thieblemont C, Topp M, Zinzani PL, Gribben JG, Bonini C, Sureda A, Yakoub-Agha I (2023) Immune effector cell-associated hematotoxicity: EHA\/EBMT consensus grading and best practice recommendations. Blood 142:865\u2013877. https:\/\/doi.org\/10.1182\/blood.2023020578","journal-title":"Blood"},{"key":"6884_CR14","unstructured":"U.S. Department of Health and Human Services (2017) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"key":"6884_CR15","doi-asserted-by":"publisher","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M, Zahner G, Seifert L, Schnarre A et al International Society of Glomerular Disease (2024) autoantibodies targeting nephrin in podocytopathies. N Engl J Med 391:422\u2013433. https:\/\/doi.org\/10.1056\/NEJMoa2314471","DOI":"10.1056\/NEJMoa2314471"},{"key":"6884_CR16","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.trim.2021.101441","volume":"68","author":"M Perosa","year":"2021","unstructured":"Perosa M, Ferreira GF, Modelli LG, Medeiros MP, Neto SR, Moreira F, Zampieri FG, de Marco R, Bortoluzzo AB, Venezuela MK (2021) Disparity in the access to kidney transplantation for sensitized patients in the state of Sao Paulo-Brazil. Transpl Immunol 68:101441. https:\/\/doi.org\/10.1016\/j.trim.2021.101441","journal-title":"Transpl Immunol"},{"key":"6884_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trim.2013.05.002","volume":"28","author":"IC Bostock","year":"2013","unstructured":"Bostock IC, Alber\u00fa J, Arvizu A, Hern\u00e1ndez-Mendez EA, De-Santiago A, Gonz\u00e1lez-Tableros N, L\u00f3pez M, Castel\u00e1n N, Contreras AG, Morales-Buenrostro LE, Gabilondo B, Vilatob\u00e1 M (2013) Probability of deceased donor kidney transplantation based on % PRA. Transpl Immunol 28:154\u2013158. https:\/\/doi.org\/10.1016\/j.trim.2013.05.002","journal-title":"Transpl Immunol"},{"key":"6884_CR18","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.ajt.2024.06.010","volume":"24","author":"P Randone","year":"2024","unstructured":"Randone P, Sanna E, Dolla C, Gallo E, Mingozzi S, Tarragoni R, Torazza MC, Niarchos A, Mella A, Manzione AM, Barreca A, Deambrosis I, Giraudi R, Biancone L (2024) Rescue with obinutuzumab and daratumumab as combined B cell\/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence. Am J Transplant 24:1896\u20131900. https:\/\/doi.org\/10.1016\/j.ajt.2024.06.010","journal-title":"Am J Transplant"},{"key":"6884_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","volume":"105","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, Hamasaki Y, Hotta K, Ito N, Honda K, Tanabe K, Takano T, Hattori M (2024) A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int 105:608\u2013617. https:\/\/doi.org\/10.1016\/j.kint.2023.11.022","journal-title":"Kidney Int"},{"key":"6884_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/TP.0000000000001160","volume":"101","author":"C Garrouste","year":"2017","unstructured":"Garrouste C, Canaud G, B\u00fcchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE (2017) Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes. Transplantation 101:649\u2013656. https:\/\/doi.org\/10.1097\/TP.0000000000001160","journal-title":"Transplantation"},{"key":"6884_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ajt.2023.12.010","volume":"24","author":"A Angeletti","year":"2024","unstructured":"Angeletti A, Bin S, Magnasco A, Bruschi M, Cravedi P, Ghiggeri GM (2024) Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 24:688\u2013692. https:\/\/doi.org\/10.1016\/j.ajt.2023.12.010","journal-title":"Am J Transplant"},{"key":"6884_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ajt.2022.11.001","volume":"23","author":"JA Hill","year":"2023","unstructured":"Hill JA, Kiem ES, Bhatti A, Liu W, Keane-Candib J, Fitzpatrick KS, Boonyaratanakornkit J, Gardner RA, Green DJ, Maloney DG, Turtle CJ, Smith JA, Gimferrer I, Blosser CD, Jackson SW (2023) Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy. Am J Transplant 23:416\u2013422. https:\/\/doi.org\/10.1016\/j.ajt.2022.11.001","journal-title":"Am J Transplant"},{"key":"6884_CR23","unstructured":"National Library of Medicine. National Center for Biotechnology Information (2024) Regeneron Pharmaceuticals. Study for desensitization of chronic kidney disease in adult patients in need of a kidney transplant who are highly sensitized to human leukocyte antigen. https:\/\/clinicaltrials.gov\/study\/NCT05092347"},{"key":"6884_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1182\/bloodadvances.2020002736","volume":"5","author":"DJ DiLillo","year":"2021","unstructured":"DiLillo DJ, Oslan K, Mohrs K, Meagher TC, Bray K, Sineshchekova O, Startz T, Kuhnert J, Retter MW, Godin S, Sharma P, Delfino F, Lin J, Smith E, Thurston G, Kirshner JR (2021) A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells. Blood Adv 5:1291\u20131304. https:\/\/doi.org\/10.1182\/bloodadvances.2020002736","journal-title":"Blood Adv"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06884-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:10:33Z","timestamp":1759234233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06884-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6884"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06884-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}